This year, many Americans have finally been getting the health care procedures they need that they put off during the pandemic. All sorts of what we call non-urgent surgical stuff. That's been great for the hospitals and most of the medical device makers, but not all of them. And that means something's wrong here. Take Zimmer Biomed. It's the leader in hip and knee replacements. It's expanded to orthopedic robotics and mixed reality devices for the operating room. Even though Zimmer is some of the best tech you'll ever find in the industry, this stock's actually down 11% for the year. Even when the company reported a really solid quarter yesterday, the stock fell more than 3%, primarily because Zimmer only reiterated most of its full-year forecast and even lowered its sales outlook. But it was about currency. So what's holding the stock back? Maybe you're getting a great buying opportunity here. Maybe I'm missing something. Let's check in with Yvonne Tornos. He's the president's CEO of Zimmer Buy, meant to get a better sense of the quarter. Mr. Tornos, welcome to Mad Money. Great to be here.

Thank you for having me.

Well, this is very exciting to have you because there's really, I've regarded it as two Zimmer Buy. There's stuff that we all know, which is the knees and hips, and then there's the stuff that you're doing now. And I just want to give you the floor to talk about what I think is one of the most exciting, actually in-use reality devices that I've ever heard about.

Yeah, we have been around for a hundred years. We are known for our knees and our hips, number one company in the world in knee reconstruction, number one company in the world in hip reconstruction. But we do much more than that. We have leading robotic applications in reconstructive, but also in brain procedures. We are the number one company that treats epilepsy with a robot that can diagnose and can implant an actual device to help your epilepsy. And nobody really has anything. Nobody has that.

That is proprietary. A lot of companies have tried to crack epilepsy and have had no luck. But you're coming at it from another way.

We do solutions like mixed reality. Think about a surgery where your surgeon can have goggles on that sees things that you cannot see. You can see parts of your anatomy. You have a hologram of your actual anatomy. You can see the instruments. You can see where to do the surgery. This means more accuracy. This means a shorter time in the opening room. You get to the hospital sooner. We do smart implants. We are the only company in the world that can make a fairly dumb device. This is a knee implant. It's been around for 60 years. Titanium, stainless steel, cobalt chrome. Now, in this implant, we can put a tiny sensor, Jim, a tiny sensor. We call it Persona IQ that is going to tell you things about your mobility that you didn't know about. It's going to feed data to you, the patient, to your surgeon, to your care team, to tell you about your recovery. Are you working the way you're supposed to be working after surgery? Is your mobility the way it's supposed to be?

This is transformational. Now, will I be able to, for instance, team up with this and find out things that I could look, or my watch? My watch, which, of course, died today because I didn't charge it. But, I mean, how tied in are you? I know you do Microsoft with Apple.

We have a full ecosystem of solutions. We think of us as a solutions company. Every product at Simmer Biomed either collects data or feeds data to another device. We have a partnership with Apple, and we're through an iWatch to your point or your iPhone. You can collect data and feed that data also to your caregiving team. Before surgery, tells the surgeon how you move, how are you behaving, what should you eat before the surgery, and what should be the best surgery with the best implant, with the right implant that is going to give you the most mobility.

Now, I'm trying to figure out how this business works. Should I be asking my GP or the person I'd be sent to to see whether they have yours? Because I would rather have yours than another company's that has a dummy.

Sounds like the right path. You should be talking about your mobility. And there is a personalized plan for every anatomy under the umbrella of Zimmerbaum and Solutions. So I will start with talking about you. What is your lifestyle? You're a pickleball player.

Yes, I am. I built a court because I can't move. I can't play tennis anymore. I can't play basketball. I can't run. This is the sport. And my wife is king or queen at it. But this is the sport for people like me. But I'm worried about my knee.

Well, you shouldn't be worried about your knee. We sponsor Peekable. We alleviate pain and improve the quality of life for people around the world. Meniscal repairs is one of the highest frequency injuries for Peekable players. And we can get you back on the court at a time you didn't expect.

But I am so afraid when you say we that there will be people watching. They'll go to the hospital, and the hospital won't have your stuff.

We are the number one company in the world. So I can just ask for you. In reconstructive surgeries. We've been around for a hundred years, and we've just been getting started. So you do know Zimmer Biomed.

Oh, no, I do, but I'm afraid some people might just say, listen, there's another company. You know, some of your opponents are big companies. They may not have as good a product, but a lot of times people don't get the best product in our country. They don't get, or they're afraid to ask because our system's so crazy.

We think about those opponents as peers, more than opponents. Our opponent is osteoarthritis. Our biggest challenge is awareness. There are 600 million patients on earth who suffer from osteoarthritis, and less than 5% do something about it.

Okay, so now we've talked about the things that are really exciting, and what I'm worried about is that people will say, wait a second. He starts out by saying, on the QAnon Council, look, we're 5% grower. I see these things, and I think that that's a baseline, and great things could happen. Am I too bullish about Zimmer Biomass?

I'm bullish as well. We got 50 new product launches in the next 30 to 36 months. We just had an investor day. We committed to growing revenue above market for the next three years.

The investor day was like Mission Impossible meets science fiction. I cannot believe what you guys are up to.

I like the way you think about it. But, again, revenue above market, EPS, earnings per share, growing faster than revenue, and free cash flow growing 70% over the next five years and returning that to shareholders.

But your price journey's monocle is ridiculously low versus all the growth you have.

Well, I'll leave that discussion to you and others. We're here to do innovation, customer-centric innovation. We're here to control the present and the future. And with this innovation, with the solutions that we have in the store, this company is getting started. This is not the same environment that you used to have.

Oh, no, when I heard you were coming on the show, I said, I'm so excited.

Well, I'm going to say, unfortunately, because many of my friends are your customers. Well, I hate to say that, but thank you.

Good enough. That's Yvonne Tordozzi, the president's CEO of Zimmer Biomit. Guys, this is an inexpensive stock in an expensive market. Take a look at it. We have money back after the break.